{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:31:44Z","timestamp":1788366704405,"version":"build-2803163510"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.ijcard.2015.06.111","type":"journal-article","created":{"date-parts":[[2015,7,4]],"date-time":"2015-07-04T18:09:02Z","timestamp":1436033342000},"page":"18-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"special_numbering":"C","title":["The feasibility and safety of Algisyl-LVR\u2122 as a method of left ventricular augmentation in patients with dilated cardiomyopathy: Initial first in man clinical results"],"prefix":"10.1016","volume":"199","author":[{"given":"Randall J.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Hinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bauernschmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Matschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Schiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani N.","family":"Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.06.111_bb0005","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/heart.83.5.596","article-title":"Heart failure: epidemiology, aetiology, and prognosis of heart failure","volume":"83","author":"McMurray","year":"2000","journal-title":"Heart"},{"issue":"15","key":"10.1016\/j.ijcard.2015.06.111_bb0010","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1001\/jama.2011.1474","article-title":"National and regional trends in heart failure hospitalization and mortality rates for medicare beneficiaries, 1998\u20132008","volume":"306","author":"Chen","year":"2011","journal-title":"JAMA"},{"issue":"35","key":"10.1016\/j.ijcard.2015.06.111_bb0015","doi-asserted-by":"crossref","first-page":"8869","DOI":"10.1016\/j.biomaterials.2013.07.028","article-title":"The effect of a peptide-modified thermo-reversible methylcellulose on wound healing and LV function in a chronic myocardial infarction rodent model","volume":"34","author":"Mihardja","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijcard.2015.06.111_bb0020","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.biomaterials.2013.12.011","article-title":"Regeneration of chronic myocardial infarction by injectable hydrogels containing stem cell homing factor SDF-1 and angiogenic peptide Ac-SDKP","volume":"35","author":"Song","year":"2014","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.ijcard.2015.06.111_bb0025","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.5966\/sctm.2014-0049","article-title":"Concise review: injectable biomaterials for the treatment of myocardial infarction and peripheral artery disease: translational challenges and progress","volume":"3","author":"Ungerleider","year":"2014","journal-title":"Stem Cells Transl. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2015.06.111_bb0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jtcvs.2008.08.036","article-title":"Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy","volume":"137","author":"Yu","year":"2009","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.ijcard.2015.06.111_bb0035","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jchf.2013.02.006","article-title":"Augmentation of left ventricular wall thickness with alginate hydrogel implants improves left ventricular function and prevents progressive remodeling in dogs with chronic heart failure","volume":"1","author":"Sabbah","year":"2013","journal-title":"JACC Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2015.06.111_bb0040","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1111\/j.1540-8191.2005.00157.x","article-title":"Initial safety and feasibility clinical trial of the myosplint device","volume":"20","author":"Fukamachi","year":"2005","journal-title":"J. Card. Surg."},{"issue":"5","key":"10.1016\/j.ijcard.2015.06.111_bb0045","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jtcvs.2011.06.014","article-title":"Beneficial effects of the CorCap cardiac support device: five-year results from the Acorn Trial","volume":"143","author":"Mann","year":"2012","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"1","key":"10.1016\/j.ijcard.2015.06.111_bb0050","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jtcvs.2007.09.034","article-title":"Worldwide surgical experience with the Paracor HeartNet cardiac restraint device","volume":"135","author":"Klodell","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.ijcard.2015.06.111_bb0055","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/j.ijcard.2013.01.003","article-title":"Algisyl-LVR\u2122 with coronary artery bypass grafting reduces left ventricular wall stress and improves function in the failing human heart","volume":"168","author":"Lee","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2015.06.111_bb0060","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.athoracsur.2007.03.095","article-title":"Acorn Trial Principal Investigators and Study Coordinators. Clinical evaluation of the CorCap Cardiac Support Device in patients with dilated cardiomyopathy","volume":"84","author":"Mann","year":"2007","journal-title":"Ann. Thorac. Surg."},{"issue":"1","key":"10.1016\/j.ijcard.2015.06.111_bb0065","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jtcvs.2007.09.034","article-title":"Worldwide surgical experience with the Paracor HeartNet cardiac restraint device","volume":"135","author":"Klodell","year":"2008","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"19","key":"10.1016\/j.ijcard.2015.06.111_bb0070","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.291.19.2319","article-title":"Terminal complement blockade with pexelizumab during coronary artery bypass graft surgery requiring cardiopulmonary bypass: a randomized trial","volume":"291","author":"Verrier","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2015.06.111_bb0075","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(03)00092-5","article-title":"Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction","volume":"41","author":"Menasche","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2015.06.111_bb0080","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/j.jacc.2003.06.017","article-title":"Catheter-based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure: clinical experience with six-month follow-up","volume":"42","author":"Smits","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.ijcard.2015.06.111_bb0085","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1161\/01.CIR.81.5.1507","article-title":"Resetting of ventricular tachycardia by single extrastimuli. Relation to slow conduction within the reentrant circuit","volume":"81","author":"Kay","year":"1990","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijcard.2015.06.111_bb0090","doi-asserted-by":"crossref","first-page":"H2171","DOI":"10.1152\/ajpheart.00427.2004","article-title":"Acute reduction of ventricular volume decreases QT interval dispersion in elderly subjects with and without heart failure","volume":"288","author":"de Carvalho","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"1","key":"10.1016\/j.ijcard.2015.06.111_bb0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cardfail.2009.09.001","article-title":"Different substrates of non-sustained ventricular tachycardia in post-infarction patients with and without left ventricular dilatation","volume":"16","author":"Di Bella","year":"2010","journal-title":"J. Card. Fail."},{"issue":"20","key":"10.1016\/j.ijcard.2015.06.111_bb0100","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/01.CIR.0000070420.51787.A8","article-title":"Left ventricular remodeling and ventricular arrhythmias after myocardial infarction","volume":"107","author":"St John Sutton","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2015.06.111_bb0105","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S1010-7940(03)00007-1","article-title":"Perioperative and postoperative arrhythmia in three-vessel coronary artery disease patients and antiarrhythmic effects of ischemic preconditioning","volume":"23","author":"Wu","year":"2003","journal-title":"Eur. J. Cardiothorac. Surg."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315300462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315300462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T00:17:12Z","timestamp":1566951432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315300462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":21,"alternative-id":["S0167527315300462"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.06.111","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The feasibility and safety of Algisyl-LVR\u2122 as a method of left ventricular augmentation in patients with dilated cardiomyopathy: Initial first in man clinical results","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.06.111","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}